Long-Term Results Following Postoperative Radiotherapy for Soft Tissue Sarcomas of the Extremity

Purpose To review long-term outcomes following postoperative radiotherapy (RT) for extremity soft tissue sarcoma (STS) and identify variables affecting the therapeutic ratio. Methods and Materials Between 1970 and 2008, 173 patients with localized extremity STS were treated with postoperative radiat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of radiation oncology, biology, physics biology, physics, 2012-11, Vol.84 (4), p.1003-1009
Hauptverfasser: McGee, Lisa, MD, Indelicato, Daniel J., MD, Dagan, Roi, MD, Morris, Christopher G., MS, Knapik, Jacquelyn A., MD, Reith, John D., MD, Scarborough, Mark T., MD, Gibbs, C. Parker, MD, Marcus, Robert B., MD, Zlotecki, Robert A., MD, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Purpose To review long-term outcomes following postoperative radiotherapy (RT) for extremity soft tissue sarcoma (STS) and identify variables affecting the therapeutic ratio. Methods and Materials Between 1970 and 2008, 173 patients with localized extremity STS were treated with postoperative radiation. No patients received prior irradiation. Sixteen percent of tumors had recurred after initial surgery alone; 89% of tumors were high grade. The median patient age was 57 years (range, 18-86 years). Sixty-one percent underwent >1 surgery before RT in an attempt to achieve wide negative margins. Final margin status was negative in 70% and marginal or microscopically positive in 30%. The median time between final surgery and start of RT was 40 days. The median RT dose was 65 Gy (range, 49-74 Gy). The median follow-up for all patients was 10.4 years and 13.2 years among survivors. Results At 10 years, local control (LC), cause-specific survival (CSS), and overall survival (OS) rates were 87%, 80%, and 70%, respectively, with 89% of local failures occurring within 3 years after treatment. On multivariate analysis, age >55 years (82% vs 93%, P
ISSN:0360-3016
1879-355X
DOI:10.1016/j.ijrobp.2012.01.074